Stent with therapeutically active dosage of rapamycin coated thereon

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6585764
SERIAL NO

09874117

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Delivery of rapamycin locally, particularly from intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CARDINAL HEALTH SWITZERLAND 515 GMBH

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
King, Kristen Hoboken, NJ 10 1352
Llanos, Gerard H Stewartsville, NJ 50 5656
Rakos, Ronald Middlesex County, NJ 38 3078
Wright, Carol Somerset, NJ 12 1405

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation